A STUDY OF ANTI-HYPERLIPIDEMIC ACTIVITY OF MARKETED FORMULATIONS OF TERMINALIA ARJUNA POWDER USING EXPERIMENTAL ANIMAL MODEL

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2015, Vol 4, Issue 1

Abstract

Hyperlipidemia is a disorder of lipid metabolism which is major risk of coronary heart disease. Now a day’s synthetic drugs have been associated with number of side effects but herbal medicines have lipid lowering and antioxidant activities without any side effects. Some traditionally herbs like: - Commiphora mukul (Gugglul), Terminalia Arjuna (Arjun), Picrorrhiza Kurroa(Kutki), Allium Sativum (Lasuna), etc. are used as Antihyperlipidemic drug in ayurvedic literature. Hence the present study was undertaken to investigate the antihyperlipidemic effect of marketed formulations of terminalia arjuna against Triton WR-1339 induced hyperlipidemia in rats at 200 and 400 mg/kg dose inhibited the elevation of serum cholesterol and triglyceride levels in hyperlipidemic rats. Marketed formulations also significantly decreased 3-hydroxy-3-methylglutaryl- CoA reductase (HMG-CoA reductase) activity at the dose of 200mg/kg and 400mg/kg; p.o. showed good antihyperlipidemic activity in Triton WR-1339 induced hyperlipidemic rats. The probable mechanism of action of the marketed formulations may be inhibition of HMG-CoA reductase enzyme pathway.

Authors and Affiliations

Sharma S| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Asija R| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Kumawat R S| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Chaudhary P| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Sharma P K| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020

Keywords

Related Articles

EFFECTS ON HAEMODYNAMICS, BIOCHEMICAL AND HEMATOLOGICAL CHANGES AFTER PRETREATMENT WITH THE KCNQ OPENER RETIGABINE AND DIACYGLYCEROL LIPASE INHIBITOR ON PROPOFOL IN THE MICE

The mechanisms of action of general anesthetics are still being unraveled. Retigabine is a KCNQ/Kv7 channel opener and has potential therapeutic importance for epilepsy. On the other hand, Propofol an inducing general an...

Does Rottlerin or its congeners have a potential as adjuvant to antidote therapy of spider/snake venom intoxication?

Rottlerin is a polyphenol natural product isolated from the tree Mallotusphilippensis. Rottlerin displays a complex spectrum of pharmacology. Rottlerin has been shown to be an uncoupler of mitochondrial oxidative phospho...

Phytochemical and Pharmacological Investigation of Hyptis suaveolens L. in Experimental Models

Hyptis suaveolens L. Poit is a plant belonging to family Lamiaceae, or the Mint family..The original family name is Labiatae, while this is still considered a suitable alternate name nearly all botanists now use the name...

A STUDY OF ANTI-HYPERLIPIDEMIC ACTIVITY OF MARKETED FORMULATIONS OF TERMINALIA ARJUNA POWDER USING EXPERIMENTAL ANIMAL MODEL

Hyperlipidemia is a disorder of lipid metabolism which is major risk of coronary heart disease. Now a day’s synthetic drugs have been associated with number of side effects but herbal medicines have lipid lowering and an...

NEPHROTOXICITY: AN OVERVIEW

Nephrotoxicity is one of the most common situations faced by people due to easy availability of over the counter medication like NSAIDs, antibiotics and angiotensin converting enzyme inhibitors etc. There are various typ...

Download PDF file
  • EP ID EP3501
  • DOI -
  • Views 398
  • Downloads 16

How To Cite

Sharma S, Asija R, Kumawat R S, Chaudhary P, Sharma P K (2015). A STUDY OF ANTI-HYPERLIPIDEMIC ACTIVITY OF MARKETED FORMULATIONS OF TERMINALIA ARJUNA POWDER USING EXPERIMENTAL ANIMAL MODEL. Journal of Biomedical and Pharmaceutical Research, 4(1), 107-111. https://europub.co.uk/articles/-A-3501